The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas, 1992-2000

被引:298
作者
Mirza, SA
Phelan, M
Rimland, D
Graviss, E
Hamill, R
Brandt, ME
Gardner, T
Sattah, M
de Leon, GP
Baughman, W
Hajjeh, RA
机构
[1] Ctr Dis Control & Prevent, Mycot Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[2] Vet Affairs Med Ctr, Atlanta, GA 30033 USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
[4] Baylor Coll Med, Houston, TX 77030 USA
[5] Vet Affairs Med Ctr, Houston, TX 77030 USA
关键词
D O I
10.1086/368091
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To examine trends in the incidence and epidemiology of cryptococcosis, active, population-based surveillance was conducted during 1992-2000 in 2 areas of the United States (the Atlanta, Georgia, and Houston, Texas, metropolitan areas; combined population, 7.4 million). A total of 1491 incident cases were detected, of which 1322 (89%) occurred in HIV-infected persons. The annual incidence of cryptococcosis per 1000 persons with AIDS decreased significantly during the study period, from 66 in 1992 to 7 in 2000 in the Atlanta area, and from 24 in 1993 to 2 in 1994 in the Houston area. Poisson regression analysis revealed that African American persons with AIDS were more likely than white persons with AIDS to develop disease. Less than one-third of all HIV-infected persons with cryptococcosis were receiving antiretroviral therapy before diagnosis. Our findings suggest that HIV-infected persons who continue to develop cryptococcosis in the era of highly active antiretroviral therapy (HAART) in the United States are those with limited access to health care. More efforts are needed to expand the availability of HAART and routine HIV care services to these persons.
引用
收藏
页码:789 / 794
页数:6
相关论文
共 19 条
  • [1] Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States
    Brandt, ME
    Hutwagner, LC
    Klug, LA
    Baughman, WS
    Rimland, D
    Graviss, EA
    Hamill, RJ
    Thomas, C
    Pappas, PG
    Reingold, AL
    Pinner, RW
    Stephens, D
    Farley, M
    Bardsley, M
    Siegel, B
    Jackson, G
    Lao, C
    Otte, J
    Harvey, C
    Gillespie, R
    Rothrock, G
    Pattni, B
    Daily, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) : 912 - 917
  • [2] *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P15
  • [3] Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: Regional variation and temporal trends
    Chariyalertsak, S
    Sirisanthana, T
    Saengwonloey, O
    Nelson, KE
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (06) : 955 - 962
  • [4] Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand
    Chen, S
    Sorrell, T
    Nimmo, G
    Speed, B
    Currie, B
    Ellis, D
    Marriott, D
    Pfeiffer, T
    Parr, D
    Byth, K
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) : 499 - 508
  • [5] INFECTIONS WITH CRYPTOCOCCUS-NEOFORMANS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    CHUCK, SL
    SANDE, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (12) : 794 - 799
  • [6] Epidemiology of cryptococcosis in France: A 9-year survey (1985-1993)
    Dromer, F
    Mathoulin, S
    Dupont, B
    Laporte, A
    Chardon, H
    Greze, H
    Hayette, MP
    Chabasse, D
    Martin, M
    Pulik, M
    Hautefort, B
    LePennec, MP
    Larfouilloux, J
    Faller, JP
    Barale, T
    BougesMichel, C
    Delzanig, G
    Couprie, B
    Bougnoux, ME
    Masure, O
    Lefort, C
    Duhamel, C
    Bidault, C
    Zaegel, M
    Allard, C
    Laurens, E
    Dormont, J
    Beytout, J
    Mollo, JL
    Boussougant, Y
    Cordier, F
    Bretagne, S
    Gaillard, JP
    Portier, H
    Grise, G
    Leblanc, A
    Bouchard, I
    Nauciel, C
    Lebeau, B
    Bouree, P
    Lagarde, A
    Vincent, J
    DesaillyChanson, MA
    Eloy, O
    Grillot, ML
    Gosset, X
    Capbern, P
    Darde, ML
    Lemercier, Y
    Piens, MA
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (01) : 82 - 90
  • [7] Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons
    Hajjeh, RA
    Conn, LA
    Stephens, DS
    Baughman, W
    Hamill, R
    Graviss, E
    Pappas, PG
    Thomas, C
    Reingold, A
    Rothrock, G
    Hutwagner, LC
    Schuchat, A
    Brandt, ME
    Pinner, RW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (02) : 449 - 454
  • [8] Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy
    Kaplan, JE
    Hanson, D
    Dworkin, MS
    Frederick, T
    Bertolli, J
    Lindegren, ML
    Holmberg, S
    Jones, JL
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 : S5 - S14
  • [9] Association of medical insurance and other factors with receipt of antiretroviral therapy
    Keruly, JC
    Conviser, R
    Moore, RD
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (05) : 852 - 857
  • [10] EPIDEMIOLOGIC DIFFERENCES BETWEEN THE 2 VARIETIES OF CRYPTOCOCCUS-NEOFORMANS
    KWONCHUNG, KJ
    BENNETT, JE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 120 (01) : 123 - 130